Stella Pharma Corp. Hits Day High with 17.71% Surge in Stock Price

Stella Pharma Corp. has experienced significant activity today, with the stock surging by 17.71% on June 18, 2026. The stock reached an intraday high of JPY 426.00, marking a notable performance against the backdrop of the Japan Nikkei 225, which rose by 1.65% on the same day. In terms of performance metrics, Stella Pharma Corp. has shown a remarkable year-to-date increase of 102.96%, significantly outperforming the Japan Nikkei 225's 41.15% gain. However, the company has faced challenges over longer periods, with a one-year performance decline of 1.20% and a five-year drop of 32.24%. The company's market capitalization stands at JPY 12,052 million, categorizing it as a small-cap entity within the pharmaceuticals and biotechnology industry. Despite the recent uptick, Stella Pharma Corp. has reported negative returns on equity and a concerning trend in operating profit growth over the past five years. Investors may want to consider these factors when evaluating the stock's performance in the broader market context.